1. Home
  2. LVWR vs SABS Comparison

LVWR vs SABS Comparison

Compare LVWR & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveWire Group Inc.

LVWR

LiveWire Group Inc.

N/A

Current Price

$0.54

Market Cap

318.4M

Sector

N/A

ML Signal

N/A

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

N/A

Current Price

$3.00

Market Cap

293.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LVWR
SABS
Founded
2022
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
318.4M
293.9M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
LVWR
SABS
Price
$0.54
$3.00
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $11.64
AVG Volume (30 Days)
327.3K
★ 656.9K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
19.57
★ 78.53
EPS
★ N/A
N/A
Revenue
★ $25,672,000.00
N/A
Revenue This Year
$604.97
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.53
$2.44
52 Week High
$5.13
$5.15

Technical Indicators

Market Signals
Indicator
LVWR
SABS
Relative Strength Index (RSI) 25.10 47.67
Support Level N/A $2.44
Resistance Level $1.71 $4.06
Average True Range (ATR) 0.19 0.24
MACD -0.12 0.03
Stochastic Oscillator 2.13 51.55

Price Performance

Historical Comparison
LVWR
SABS

About LVWR LiveWire Group Inc.

LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

Share on Social Networks: